ImmunoGen, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $8.7 Billion | 1/16 | IMGN $8.7B |
MDGL $7.4B |
RETA $6.6B |
AXSM $6.4B |
TGTX $4.8B |
VKTX $3.3B |
ICPT $794.7M |
TERN $368.6M |
MCRB $140.0M |
INZY $86.7M |
XFOR $80.2M |
PDSB $47.9M |
ELEV $36.7M |
HOOK $18.2M |
HEPA $2.1M |
EFTR $0 |
Gross Margin | 98% | 2/16 | ICPT 100% |
IMGN 98% |
MDGL 97% |
RETA 96% |
AXSM 92% |
TGTX 89% |
XFOR 18% |
VKTX 0% |
MCRB 0% |
HEPA 0% |
HOOK 0% |
PDSB 0% |
INZY 0% |
ELEV 0% |
TERN 0% |
EFTR 0% |
Profit Margin | 27% | 3/16 | RETA 100% |
XFOR 100% |
IMGN 27% |
TGTX 5% |
VKTX 0% |
MCRB 0% |
HEPA 0% |
HOOK 0% |
PDSB 0% |
INZY 0% |
ELEV 0% |
TERN 0% |
EFTR 0% |
ICPT -3% |
AXSM -62% |
MDGL -100% |
EBITDA margin | 27% | 1/16 | IMGN 27% |
TGTX 18% |
ICPT -3% |
AXSM -60% |
VKTX -100% |
MCRB -100% |
HEPA -100% |
HOOK -100% |
PDSB -100% |
INZY -100% |
ELEV -100% |
TERN -100% |
EFTR -100% |
MDGL -166% |
RETA -356% |
XFOR -5986% |
Quarterly Revenue | $113.4 Million | 1/16 | IMGN $113.4M |
AXSM $104.8M |
ICPT $88.8M |
TGTX $83.9M |
MDGL $62.2M |
RETA $22.7M |
XFOR $563,000 |
VKTX $0 |
MCRB $0 |
HEPA $0 |
HOOK $0 |
PDSB $0 |
INZY $0 |
ELEV $0 |
TERN $0 |
EFTR $0 |
Quarterly Earnings | $30.7 Million | 4/16 | RETA $193.0M |
XFOR $90.8M |
MCRB $88.8M |
IMGN $30.7M |
TGTX $3.9M |
ICPT -$2.8M |
HEPA -$4.9M |
EFTR -$8.8M |
ELEV -$12.9M |
HOOK -$13.8M |
TERN -$21.9M |
INZY -$24.6M |
VKTX -$24.9M |
AXSM -$64.6M |
MDGL -$107.0M |
PDSB -$10.7B |
Quarterly Free Cash Flow | $1.4 Million | 2/16 | ICPT $3.9M |
IMGN $1.4M |
HEPA -$2.5M |
EFTR -$7.3M |
TGTX -$12.2M |
TERN -$16.5M |
ELEV -$16.6M |
HOOK -$17.5M |
AXSM -$18.5M |
VKTX -$22.0M |
INZY -$24.5M |
XFOR -$30.4M |
MCRB -$34.8M |
MDGL -$62.8M |
RETA -$70.2M |
PDSB -$26.8B |
Trailing 4 Quarters Revenue | $329.6 Million | 2/16 | AXSM $338.5M |
IMGN $329.6M |
ICPT $317.7M |
TGTX $264.8M |
MDGL $76.8M |
HOOK $45.3M |
RETA $24.4M |
XFOR $563,000 |
MCRB $64,000 |
VKTX $0 |
HEPA $0 |
PDSB $0 |
INZY $0 |
ELEV $0 |
TERN $0 |
EFTR $0 |
Trailing 4 Quarters Earnings | -$18.3 Million | 3/16 | IMGN $113.4M |
AXSM $104.8M |
ICPT $88.8M |
TGTX $83.9M |
MDGL $62.2M |
RETA $22.7M |
XFOR $563,000 |
VKTX -$0 |
MCRB -$0 |
HEPA -$0 |
HOOK -$0 |
PDSB -$0 |
INZY -$0 |
ELEV -$0 |
TERN -$0 |
EFTR -$0 |
Quarterly Earnings Growth | 175% | 4/16 | RETA 362% |
MCRB 286% |
XFOR 263% |
IMGN 175% |
HEPA 54% |
HOOK 27% |
TERN 26% |
EFTR 10% |
AXSM -4% |
MDGL -8% |
VKTX -11% |
ELEV -21% |
INZY -48% |
TGTX -97% |
ICPT -101% |
PDSB -98771% |
Annual Earnings Growth | 92% | 2/16 | XFOR 108% |
IMGN 92% |
RETA 72% |
HEPA 57% |
TGTX 50% |
HOOK 41% |
EFTR 12% |
ELEV -2% |
TERN -6% |
AXSM -18% |
VKTX -24% |
MDGL -46% |
INZY -52% |
ICPT -124% |
MCRB -128% |
PDSB -43780% |
Quarterly Revenue Growth | 127% | 2/16 | RETA 2885% |
IMGN 127% |
AXSM 81% |
ICPT 14% |
VKTX 0% |
MDGL 0% |
HEPA 0% |
HOOK 0% |
PDSB 0% |
XFOR 0% |
INZY 0% |
ELEV 0% |
TERN 0% |
EFTR 0% |
TGTX -49% |
MCRB -100% |
Annual Revenue Growth | 90% | 2/16 | RETA 596% |
IMGN 90% |
AXSM 71% |
TGTX 24% |
ICPT 8% |
VKTX 0% |
MDGL 0% |
HEPA 0% |
HOOK 0% |
PDSB 0% |
XFOR 0% |
INZY 0% |
ELEV 0% |
TERN 0% |
EFTR 0% |
MCRB -100% |
Cash On Hand | $605.5 Million | 2/16 | PDSB $49.8B |
IMGN $605.5M |
AXSM $327.3M |
TERN $270.1M |
MDGL $232.7M |
TGTX $195.8M |
XFOR $147.2M |
ICPT $102.7M |
MCRB $66.8M |
HOOK $59.8M |
VKTX $50.3M |
RETA $48.8M |
ELEV $48.2M |
INZY $24.6M |
EFTR $15.5M |
HEPA $1.5M |
Short Term Debt | $24.9 Million | 16/16 | PDSB $59.7M |
EFTR $19.0M |
MCRB $8.3M |
INZY $4.6M |
RETA $2.5M |
HEPA $2.2M |
AXSM $1.6M |
TGTX $1.2M |
HOOK $1.2M |
XFOR $1.2M |
MDGL $878,000 |
VKTX $480,000 |
TERN $272,000 |
ICPT -$0 |
ELEV -$0 |
IMGN -$24.9M |
Long Term Debt | $72.1 Million | 8/16 | ICPT $223.9M |
AXSM $189.4M |
RETA $163.5M |
MDGL $118.3M |
MCRB $85.3M |
PDSB $77.7M |
XFOR $75.0M |
IMGN $72.1M |
INZY $42.2M |
ELEV $31.0M |
TGTX $8.4M |
HOOK $1.6M |
TERN $1.0M |
VKTX $755,000 |
EFTR $179,000 |
HEPA $0 |
PE | -1.00 | 2/16 | XFOR 4.55 |
IMGN -1.00 |
VKTX -1.00 |
RETA -1.00 |
TGTX -1.00 |
ICPT -1.00 |
MDGL -1.00 |
AXSM -1.00 |
MCRB -1.00 |
HEPA -1.00 |
HOOK -1.00 |
PDSB -1.00 |
INZY -1.00 |
ELEV -1.00 |
TERN -1.00 |
EFTR -1.00 |
PS | 26.48 | 5/16 | MCRB 2187.58 |
RETA 269.17 |
XFOR 142.37 |
MDGL 96.59 |
IMGN 26.48 |
AXSM 18.84 |
TGTX 18.29 |
ICPT 2.50 |
HOOK 0.40 |
VKTX -1.00 |
HEPA -1.00 |
PDSB -1.00 |
INZY -1.00 |
ELEV -1.00 |
TERN -1.00 |
EFTR -1.00 |
PB | 15.54 | 4/16 | RETA 75.22 |
AXSM 68.63 |
TGTX 25.20 |
IMGN 15.54 |
ICPT 11.06 |
MDGL 9.55 |
MCRB 5.85 |
VKTX 3.66 |
INZY 1.05 |
TERN 1.01 |
XFOR 0.85 |
ELEV 0.53 |
HOOK 0.25 |
HEPA 0.00 |
PDSB 0.00 |
EFTR 0.00 |
PC | 14.41 | 6/16 | RETA 134.44 |
VKTX 66.31 |
MDGL 31.89 |
TGTX 24.73 |
AXSM 19.48 |
IMGN 14.41 |
ICPT 7.74 |
INZY 3.53 |
MCRB 2.10 |
HEPA 1.42 |
TERN 1.36 |
ELEV 0.76 |
XFOR 0.54 |
HOOK 0.31 |
PDSB 0.00 |
EFTR 0.00 |
Liabilities to Equity | 0.46 | 12/16 | EFTR 31.81 |
MCRB 6.47 |
AXSM 5.04 |
RETA 4.76 |
ICPT 4.47 |
TGTX 2.05 |
PDSB 1.38 |
XFOR 1.23 |
INZY 0.73 |
HOOK 0.53 |
ELEV 0.53 |
IMGN 0.46 |
MDGL 0.38 |
TERN 0.04 |
VKTX 0.03 |
HEPA 0.00 |
ROA | -0.02 | 2/16 | XFOR 8% | IMGN -2% | TGTX -2% | VKTX -11% | MCRB -14% | ICPT -15% | RETA -16% | TERN -23% | PDSB -38% | ELEV -39% | HOOK -40% | MDGL -48% | AXSM -55% | INZY -67% | EFTR -128% | HEPA -611% |
ROE | -0.03 | 3/16 | HEPA 5583% |
XFOR 19% |
IMGN -3% |
TGTX -7% |
VKTX -11% |
TERN -24% |
HOOK -60% |
ELEV -60% |
MDGL -67% |
ICPT -82% |
PDSB -91% |
RETA -94% |
MCRB -107% |
INZY -117% |
AXSM -335% |
EFTR -4187% |
Current Ratio | 3.16 | 4/16 | VKTX 35.47 |
TERN 27.48 |
MDGL 3.62 |
IMGN 3.16 |
HOOK 2.89 |
ELEV 2.88 |
INZY 2.37 |
XFOR 1.81 |
PDSB 1.72 |
TGTX 1.49 |
ICPT 1.22 |
RETA 1.21 |
AXSM 1.20 |
MCRB 1.15 |
EFTR 1.03 |
HEPA 0.90 |
Quick Ratio | 2.32 | 5/16 | XFOR 4.55 |
IMGN -1.00 |
VKTX -1.00 |
RETA -1.00 |
TGTX -1.00 |
ICPT -1.00 |
MDGL -1.00 |
AXSM -1.00 |
MCRB -1.00 |
HEPA -1.00 |
HOOK -1.00 |
PDSB -1.00 |
INZY -1.00 |
ELEV -1.00 |
TERN -1.00 |
EFTR -1.00 |
Long Term Debt to Equity | 0.13 | 10/16 | MCRB} 3.56 |
ICPT} 3.12 |
AXSM} 2.04 |
RETA} 1.87 |
XFOR} 0.79 |
INZY} 0.51 |
ELEV} 0.45 |
EFTR} 0.22 |
MDGL} 0.15 |
IMGN} 0.13 |
TGTX} 0.04 |
HOOK} 0.02 |
VKTX} 0.00 |
HEPA} 0.00 |
PDSB} 0.00 |
TERN} 0.00 |
Debt to Equity | 0.13 | 9/16 | EFTR 23.15 |
MCRB 3.91 |
ICPT 3.12 |
AXSM 2.06 |
RETA 1.90 |
XFOR 0.83 |
INZY 0.57 |
ELEV 0.45 |
IMGN 0.13 |
TGTX 0.05 |
HOOK 0.04 |
PDSB 0.01 |
VKTX 0.00 |
MDGL 0.00 |
TERN 0.00 |
HEPA -5.47 |
Burn Rate | -17.77 | 15/16 | TERN 12.25 |
ICPT 8.75 |
PDSB 4.63 |
AXSM 4.51 |
HOOK 4.21 |
ELEV 3.41 |
MDGL 2.08 |
VKTX 2.01 |
EFTR 1.14 |
INZY 0.90 |
HEPA 0.28 |
RETA -0.26 |
MCRB -0.80 |
XFOR -1.68 |
IMGN -17.77 |
TGTX -60.52 |
Cash to Cap | 0.07 | 10/16 | PDSB 1039.00 |
HOOK 3.27 |
XFOR 1.84 |
ELEV 1.32 |
TERN 0.73 |
HEPA 0.70 |
MCRB 0.48 |
INZY 0.28 |
ICPT 0.13 |
IMGN 0.07 |
AXSM 0.05 |
TGTX 0.04 |
MDGL 0.03 |
VKTX 0.02 |
RETA 0.01 |
EFTR |
CCR | 0.05 | 11/16 | PDSB 2.50 |
ELEV 1.29 |
HOOK 1.27 |
INZY 1.00 |
VKTX 0.88 |
EFTR 0.82 |
TERN 0.75 |
MDGL 0.59 |
HEPA 0.52 |
AXSM 0.29 |
IMGN 0.05 |
XFOR -0.33 |
RETA -0.36 |
MCRB -0.39 |
ICPT -1.38 |
TGTX -3.15 |
EV to EBITDA | 267.45 | 2/16 | TGTX} 308.38 |
IMGN} 267.45 |
HOOK} 2.07 |
XFOR} -0.33 |
VKTX} -1.00 |
HEPA} -1.00 |
PDSB} -1.00 |
INZY} -1.00 |
ELEV} -1.00 |
TERN} -1.00 |
EFTR} -1.00 |
MCRB} -5.72 |
MDGL} -69.79 |
RETA} -82.50 |
AXSM} -99.62 |
ICPT} -331.82 |
EV to Revenue | 24.86 | 4/16 | MCRB 2606.14 |
RETA 273.97 |
MDGL 93.57 |
IMGN 24.86 |
XFOR 19.83 |
AXSM 18.43 |
TGTX 17.59 |
ICPT 2.88 |
HOOK -0.85 |
VKTX -1.00 |
HEPA -1.00 |
PDSB -1.00 |
INZY -1.00 |
ELEV -1.00 |
TERN -1.00 |
EFTR -1.00 |